ICU Medical, Inc. (NASDAQ:ICUI) Shares Sold by Bank of America Corp DE

Bank of America Corp DE decreased its holdings in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 12.4% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 202,021 shares of the medical instruments supplier's stock after selling 28,668 shares during the period. Bank of America Corp DE owned approximately 0.83% of ICU Medical worth $31,348,000 at the end of the most recent quarter.

Other institutional investors have also bought and sold shares of the company. Harvest Fund Management Co. Ltd purchased a new position in shares of ICU Medical during the 4th quarter worth $33,000. Quarry LP increased its position in ICU Medical by 764.3% during the fourth quarter. Quarry LP now owns 242 shares of the medical instruments supplier's stock worth $38,000 after purchasing an additional 214 shares during the last quarter. Murphy & Mullick Capital Management Corp purchased a new position in ICU Medical during the fourth quarter worth about $52,000. Venturi Wealth Management LLC raised its stake in ICU Medical by 64.0% during the fourth quarter. Venturi Wealth Management LLC now owns 528 shares of the medical instruments supplier's stock worth $82,000 after purchasing an additional 206 shares during the period. Finally, Russell Investments Group Ltd. boosted its holdings in ICU Medical by 88.8% in the 4th quarter. Russell Investments Group Ltd. now owns 638 shares of the medical instruments supplier's stock valued at $99,000 after purchasing an additional 300 shares during the last quarter. 96.10% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, COO Christian B. Voigtlander sold 5,555 shares of the business's stock in a transaction dated Monday, May 19th. The stock was sold at an average price of $138.00, for a total transaction of $766,590.00. Following the completion of the transaction, the chief operating officer now directly owns 2,389 shares of the company's stock, valued at approximately $329,682. The trade was a 69.93% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Elisha W. Finney sold 600 shares of the company's stock in a transaction that occurred on Monday, May 19th. The stock was sold at an average price of $138.92, for a total transaction of $83,352.00. Following the sale, the director now owns 3,252 shares in the company, valued at $451,767.84. The trade was a 15.58% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 21,208 shares of company stock worth $2,926,969 in the last ninety days. 1.50% of the stock is owned by corporate insiders.

ICU Medical Trading Down 1.1%

Shares of ICU Medical stock traded down $1.39 on Thursday, reaching $129.36. The company had a trading volume of 20,080 shares, compared to its average volume of 276,775. The firm's 50 day moving average price is $140.42 and its two-hundred day moving average price is $153.32. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.03 and a current ratio of 2.29. ICU Medical, Inc. has a 52-week low of $100.91 and a 52-week high of $196.26. The firm has a market cap of $3.18 billion, a PE ratio of -28.32 and a beta of 0.87.

ICU Medical (NASDAQ:ICUI - Get Free Report) last announced its earnings results on Thursday, May 8th. The medical instruments supplier reported $1.72 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.23 by $0.49. ICU Medical had a positive return on equity of 5.05% and a negative net margin of 4.74%. The company had revenue of $599.49 million for the quarter, compared to analyst estimates of $574.15 million. During the same quarter in the previous year, the company earned $0.96 earnings per share. The firm's quarterly revenue was up 6.7% compared to the same quarter last year. Sell-side analysts predict that ICU Medical, Inc. will post 4.11 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on ICUI. StockNews.com upgraded shares of ICU Medical from a "hold" rating to a "buy" rating in a report on Sunday. KeyCorp cut their target price on ICU Medical from $209.00 to $191.00 and set an "overweight" rating for the company in a research note on Monday, April 21st. Raymond James reduced their target price on ICU Medical from $197.00 to $187.00 and set a "strong-buy" rating on the stock in a research report on Friday, May 9th. Finally, Needham & Company LLC reiterated a "hold" rating on shares of ICU Medical in a report on Tuesday, April 8th. One analyst has rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, ICU Medical has a consensus rating of "Buy" and a consensus price target of $192.67.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.